Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Pulsed electric field treatment may help the immune system fight liver tumors.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Tofacitinib is effective and safe for treating alopecia areata.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Netherton syndrome is a genetic skin disorder causing severe skin issues and requires careful treatment to protect the skin barrier.

A man developed skin issues from cancer medication, which improved with specific treatments.

Talquetamab may cause hair loss and skin issues.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.